Skip to main content
editorial
. 2021 Sep 16;42(43):4478–4481. doi: 10.1093/eurheartj/ehab650

graphic file with name ehab650f1.jpg

Summary findings (A) Pharmacological effect of loop diuretics in healthy individuals showing CPDSR and the breaking phenomenon. (B) Potential therapies targeting sodium avidity in AHF and CHF. (C) Theoretical effect of therapies used in AHF and CHF on renal sodium excretion throughout the day.